Evidence map›Paper›PMID 37869668›Full record

ArticleFrontiers in microbiology2023

Antimicrobial activity, membrane interaction and structural features of short arginine-rich antimicrobial peptides.

Bruna Agrillo, Alessandra Porritiello, Lorena Gratino, Marco Balestrieri, Yolande Therese Proroga, Andrea Mancusi, Loredana Cozzi, Teresa Vicenza, Principia Dardano, Bruno Miranda and 3 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
5.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 29 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Anti-Herpetic Activity of Killer Peptide (KP): An In Vitro Study.International journal of molecular sciences · 2024
    Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 2 countries.

Bruna AgrilloAmpure S.R.L., Napoli, Italy.
Alessandra PorritielloNational Research Council (IBBR-CNR), Institute of Biosciences and Bioresources, Napoli, Italy.
Lorena GratinoNational Research Council (IBBR-CNR), Institute of Biosciences and Bioresources, Napoli, Italy.
Marco BalestrieriNational Research Council (IBBR-CNR), Institute of Biosciences and Bioresources, Napoli, Italy.
Yolande Therese ProrogaDepartment of Food Microbiology, Istituto Zooprofilattico Sperimentale del Mezzogiorno, Portici, Italy.
Andrea MancusiDepartment of Food Microbiology, Istituto Zooprofilattico Sperimentale del Mezzogiorno, Portici, Italy.
Loredana CozziDepartment of Food Safety, Nutrition and Veterinary Public Health, Istituto Superiore di Sanità, Rome, Italy.
Teresa VicenzaDepartment of Food Safety, Nutrition and Veterinary Public Health, Istituto Superiore di Sanità, Rome, Italy.
Principia DardanoNational Research Council (ISASI-CNR), Institute of Applied Sciences and Intelligent Systems, Napoli, Italy.
Bruno MirandaNational Research Council (ISASI-CNR), Institute of Applied Sciences and Intelligent Systems, Napoli, Italy.
Pablo V EscribáLaboratory of Molecular Cell Biomedicine, University of the Balearic Islands, Palma, Spain.
Marta GogliettinoNational Research Council (IBBR-CNR), Institute of Biosciences and Bioresources, Napoli, Italy.
Gianna PalmieriNational Research Council (IBBR-CNR), Institute of Biosciences and Bioresources, Napoli, Italy.
Institute of Biosciences and Bioresources · ITNational Research Council · ITIstituto Superiore di Sanità · ITIstituto Zooprofilattico Sperimentale del Mezzogiorno · ITUniversitat de les Illes Balears · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antimicrobial activity of many AMPs can be improved by lysine-to-arginine substitution due to a more favourable interaction of arginine guanidinium moiety with bacterial membranes. In a previous work, the structural and functional characterization of an amphipathic antimicrobial peptide named RiLK1, including lysine and arginine as the positively charged amino acids in its sequence, was reported. Specifically, RiLK1 retained its β-sheet structure under a wide range of environmental conditions (temperature, pH, and ionic strength), and exhibited bactericidal activity against Gram-positive and Gram-negative bacteria and fungal pathogens with no evidence of toxicity on mammalian cells. To further elucidate the influence of a lysine-to-arginine replacement on RiLK1 conformational properties, antimicrobial activity and peptide-liposome interaction, a new RiLK1-derivative, named RiLK3, in which the lysine is replaced with an arginine residue, was projected and characterised in comparison with its parental compound. The results evidenced that lysine-to-arginine mutation not only did not assure an improvement in the antimicrobial potency of RiLK1 in terms of bactericidal, virucidal and fungicidal activities, but rather it was completely abolished against the hepatitis A virus. Therefore, RiLK1 exhibited a wide range of antimicrobial activity like other cationic peptides, although the exact mechanisms of action are not completely understood. Moreover, tryptophan fluorescence measurements confirmed that RiLK3 bound to negatively charged lipid vesicles with an affinity lower than that of RiLK1, although no substantial differences from the structural and self-assembled point of view were evidenced. Therefore, our findings imply that antimicrobial efficacy and selectivity are affected by several complex and interrelated factors related to substitution of lysine with arginine, such as their relative proportion and position. In this context, this study could provide a better rationalisation for the optimization of antimicrobial peptide sequences, paving the way for the development of novel AMPs with broad applications.

Indexed as

antimicrobial compoundargininecationic arginine-rich peptidemembrane interactionspectroscopy

Identifiers

PMID37869668
PMCPMC10585156
OpenAlexW4387375672

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.